The FTO Obesity Gene. Genotyping and Gene Expression Analysis in Morbidly Obese Patients
Obesity has emerged as one of the most serious public health concerns in the twenty-first century. the fat mass and obesity associated gene (FTO) has been found to contribute to the risk of obesity in humans. Our aims in this study were to investigate the association of rs9939609 single nucleotide polymorphism (SNP) of the FTO gene with different obesity-related parameters, to assess the FTO gene expression in subcutaneous and visceral adipose tissues from morbidly obese and its correlations with other adipocytokine gene expressions.
The association between the rs9939609 FTO gene variant and obesity related parameters in 75 obese/morbidly obese adult patients and 180 subjects with body mass index (BMI) < 30 kg/m2 (control group) was examined. Gene expression analyses: subcutaneous adipose tissue samples were obtained from 52 morbidly obese and five subjects with BMI < 30 kg/m2. Visceral adipose tissue was also obtained from 35 morbidly obese patients. Weight, height, BMI, SBP, DBP, fasting glucose, lipid profile, proinsulin, insulin, leptin, and adiponectin (RIA) of patients were also obtained. Insulin resistance by HOMAIR. rs9939609 of FTO genotyping using allele discrimination in real-time PCR. Genomic study of RNA extraction of adipose tissue and real-time PCR (RT-PCR) of adipocytokines and a housekeeping gene were quantified using TaqMan probes. Relative quantification was calculated using the ΔΔ Ct formula.
The minor-(A) allele frequency of rs9939609 FTO gene in the whole population was 0.39. A strong association between this A allele and obesity was found, even after age–sex adjustment (p = 0.013). We found higher levels of FTO mRNA in subcutaneous adipose tissue from morbidly obese than in the control group (p = 0.021). FTO gene expression was lower in visceral than in subcutaneous adipose depot. However, this finding did not reach the level of statistical significance. A negative correlation between subcutaneous FTO gene expression and serum triglyceride levels and a positive correlation with leptin, perilipin, and visfatin gene expressions was found. In the visceral adipose tissue, these positive correlations were statistically significant only for perilipin.
Our results show: (1) A strong association between rs9939609 SNP of the FTO gene variant and obesity in Spanish morbidly obese adult patients; (2) positive correlations between FTO mRNA and leptin, perilipin, and visfatin gene expressions in subcutaneous adipose tissue; (3) FTO and perilipin gene expressions were positively correlated in visceral fat depot. Overall these results may suggest a role of FTO in the regulation of lipolysis as well as in total body fat rather in fat distribution patterns.
- Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132:2087–102. CrossRef
- Oguma Y, Sesso H, Paffenbarger R, et al. Weight change and risk of developing type 2 diabetes. Obes Res 2005;13:945–51. CrossRef
- Steffes MW, Gross MD, Lee DH, et al. Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study. Obesity (Silver Spring). 2006;14:319–26. CrossRef
- Irigaray P, Newby JA, Lacomme S, et al. Overweight/obesity and cancer genesis: more than a biological link. Biomed Pharmacother. 2007;6:665–78.
- Barness LA, Opitz JM, Gilbert-Barness E. Obesity: genetic, molecular, and environmental aspects. Am J Med Genet A. 2007;143:3016–34.
- Frühbeck G. The Sir David Cuthbertson Medal Lecture. Hunting for new pieces to the complex puzzle of obesity. Proc Nutr Soc. 2006;65:329–47.
- Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predispones to childhood and adult obesity. Science 2007;316:889–94. CrossRef
- van der Hoeven F, Schimmang T, Volkmann A, et al. Programmed cell death is affected in the novel mouse mutant Fused toes (Ft). Development. 1994;120:2601–7.
- Peters T, Ausmeier K, Dildrop R, et al. The mouse Fused toes (Ft) mutation is the result of a 1.6-Mb deletion including the entire Iroquois B gene cluster. Mamm Genome. 2002;13:186–8. CrossRef
- Gerken T, Girard CA, Tung YC, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007;318:1469–72. CrossRef
- Wåhlén K, Sjölin E, Hoffstedt J. The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis. J Lipid Res. 2008;49:607–11. CrossRef
- Klöting N, Schleinitz D, Ruschke K, et al. Inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans. Diabetologia. 2008;51:641–7. CrossRef
- Stratigopoulos G, Padilla S, Leduc CA, et al. Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1185–96.
- Stratakis CA, Lafferty A, Taymans SE, et al. Anisomastia associated with interstitial duplication of chromosome 16, mental retardation, obesity, dysmorphic facies, and digital anomalies: molecular mapping of a new syndrome by fluorescent in situ hybridization and microsatellites to 16q13 (D16S419-D16S503). J Clin Endocrinol Metab. 2000;85:3396–401. CrossRef
- Gonzalez-Sanchez JL, Zabena C, Martinez-Larrad MT et al. Variant rs9939609 in the FTO gene is associated with obesity in an adult population from Spain. Clin Endocrinol (Oxf). 2008; doi: 10.1111/j.1365–2265.2008.03335.
- Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39:724–6. CrossRef
- Scuteri A, Sanna S, Chen WM, et al. Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits. PLoS Genet. 2007;3:e115. CrossRef
- Li H, Wu Y, Loos RJ, et al. Variants in the fat mass-and obesity-associated (FTO) gene are not associated with obesity in a Chinese Han population. Diabetes 2008;57:264–8. CrossRef
- Ohashi J, Naka I, Kimura R, et al. FTO polymorphisms in oceanic populations. J Hum Genet. 2007;52:1031–5. CrossRef
- Martinez-Larrad MT, Fernandez-Perez C, Gonzalez-Sanchez JL, et al. Population-based study of rural and urban areas in the Spanish province of Segovia. Med Clin (Barc). 2005;125:481–6. CrossRef
- Sanchez-Pernaute A, Rubio Herrera MA, Perez-Aguirre E, et al. Proximal duodenal-ileal end-to-side bypass with sleeve gastrectomy: proposed technique. Obes Surg. 2007;17:1614–8. CrossRef
- Mason EE. Morbid obesity: use of vertical banded gastroplasty. Surg Clin North Am. 1987;67:521–37.
- Larrad-Jimenez A, Díaz-Guerra CS, de Cuadros Borrajo P, et al. Short-, mid- and long-term results of Larrad biliopancreatic diversion. Obes Surg 2007;17:202–10. CrossRef
- Diagnosis and Classification of Diabetes Mellitus. ADA. Diabetes Care 2008;31:S55-S60.
- Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. CrossRef
- Ascaso JF, Romero P, Real JT, et al. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a nondiabetic population. Med Clin (Barc). 2001;117:530–3.
- Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543–6. CrossRef
- Greenberg AS, Egan JJ, Wek SA, et al. Perilipin, a major hormonally regulated adipocyte specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem 1991;266:11341–6.
- Fasshauer M, Klein J, Neumann S, et al. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2002;290:1084–9. CrossRef
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–8. CrossRef
- Andreasen CH, Stender-Petersen KL, et al. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes. 2008;57:95–101. CrossRef
- Freathy RM, Timpson NJ, Lawlor DA, et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes. 2008;57:1419–26. CrossRef
- Perry JR, Frayling TM. New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr Opin Clin Nutr Metab Care 2008;11:371–7. CrossRef
- Hotta K, Nakata Y, Matsuo T, et al. Variations in the FTO gene are associated with severe obesity in the Japanese. J Hum Genet 2008;53:546–53. CrossRef
- Grant SF, Li M, Bradfield JP, et al. Association analysis of the FTO gene with obesity in children of Caucasian and African ancestry reveals a common tagging SNP. PLoS ONE. 2008;3r:e1746. CrossRef
- Loos RJ, Bouchard C. FTO: the first gene contributing to common forms of human obesity. Obes Rev 2008;9:246–50. CrossRef
- Ng MC, Park KS, Oh B, et al. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2 and FTO in type 2 diabetes and obesity in 6719 Asians. Diabetes 2008;57:2226–33. CrossRef
- Cha SW, Choi SM, Kim KS et al. Replication of genetic effects of FTO polymorphisms on BMI in a Korean population. Obesity 2008. doi:10.1038/oby.2008.314
- Chang YC, Liu PH, Lee WJ, et al. Common variation in the FTO gene confers risk of obesity and modulates body mass index in the Chinese population. Diabetes 2008;57:2245–52. CrossRef
- Chu X, Erdman R, Susek M, et al. Association of morbid obesity with FTO and INSIG2 allelic variants. Arch Surg 2008;143:235–40. CrossRef
- Wardle J, Carnell S, Haworth CM et al. Obesity-associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab 2008;93:3640–3. CrossRef
- Speakman JR, Rance KA, Johnstone AM. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity 2008;16:1961–5. CrossRef
- Haupt A, Thamer C, Machann J, et al. Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss. Obesity 2008;16:1969–72. CrossRef
- Vidal H, Auboeuf D, De Vos P, et al. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest. 1996;98:251–5. CrossRef
- Van Harmelen V, Reynisdottir S, Eriksson P, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998;47:913–7. CrossRef
- Bulló M, García-Lorda P, Peinado-Onsurbe J, et al. TNFalpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. Int J Obes Relat Metab Disord. 2002;26:652–8. CrossRef
- Williams LB, Fawcett RL, Waechter AS, et al. Leptin production in adipocytes from morbidly obese subjects: stimulation by dexamethasone, inhibition with troglitazone, and influence of gender. J Clin Endocrinol Metab. 2000;85:2678–84. CrossRef
- Fredriksson R, Hägglund M, Olszewski PK, et al. The Obesity Gene, FTO, Is of Ancient Origin, Up-Regulated during Food Deprivation and Expressed in Neurons of Feeding-Related Nuclei of the Brain. Endocrinology. 2008;149:2062–71. CrossRef
- Kern PA, Di Gregorio G, Lu T, et al. Perilipin expression in human adipose tissue is elevated with obesity. J Clin Endocrinol Metab. 2004;89:1352–8. CrossRef
- Lopez-Bermejo A, Petry CJ, Diaz M, et al. The association between the FTO gene and fat mass in humans develops by the postnatal age of two weeks. J Clin Endocrinol Metab. 2008;93:1501–5. CrossRef
- The FTO Obesity Gene. Genotyping and Gene Expression Analysis in Morbidly Obese Patients
Volume 19, Issue 1 , pp 87-95
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Gene expression
- Adipose tissue
- Industry Sectors
- Author Affiliations
- 1. Department of Internal Medicine II, Hospital Clínico San Carlos, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Cea Bermúdez 66, 5 G., 28003, Madrid, Spain
- 2. Department of Surgery II, Hospital Clínico San Carlos, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain
- 3. Department of Surgery I, Hospital Clínico San Carlos, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain